Provision of gastroprotective medication and bleeding risk following acute coronary syndrome

Athar Badar, Jennifer Scaife, Andrew T. Yan, Simon D. Robinson, Azfar G. Zaman, Ian F. Purcell, Javed M. Ahmed, Mohaned Egred, Richard J. Edwards, Ioakim Spyridopoulos, Bernard D. Keavney, Alan J. Bagnall

    Research output: Contribution to journalArticlepeer-review


    BACKGROUND: Gastrointestinal (GI) bleeding following percutaneous coronary intervention (PCI) is associated with increased mortality. ACCF/AHA/SCAI guidelines recommend prophylaxis to prevent GI bleeding in patients, with the highest GI bleeding risks taking dual-antiplatelet therapy (DAPT). The REPLACE risk score identifies factors predictive of peri-PCI bleeding from vascular access and non-access sites. We determined whether high bleeding risk acute coronary syndrome (ACS) patients taking DAPT were appropriately provided with GI prophylaxis and investigated the association between age and clinical presentation on the likelihood of receiving prophylactic therapy. METHODS: This is a retrospective analysis of all non-elective PCI patients at a single center between May and December 2008 stratified by age (
    Original languageEnglish
    Pages (from-to)397-401
    Number of pages4
    JournalJournal of Invasive Cardiology
    Issue number8
    Publication statusPublished - Aug 2013


    • acute coronary syndrome
    • bleeding
    • delivery of care
    • risk stratification


    Dive into the research topics of 'Provision of gastroprotective medication and bleeding risk following acute coronary syndrome'. Together they form a unique fingerprint.

    Cite this